GALM
Basic information
Region (hg38): 2:38666081-38741237
Links
Phenotypes
GenCC
Source:
- galactosemia 4 (Moderate), mode of inheritance: AR
- galactosemia 4 (Strong), mode of inheritance: AR
- galactosemia 4 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Galactosemia IV | AR | Biochemical | Dietary management (with a galactose-free diet) has been reported as resulting in normal galactose levels; some have been reported as resuming a normal diet in childhood and maintaining normal galactose levels | Biochemical; Ophthalmologic | 30451973; 30910422 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (48 variants)
- Inborn_genetic_diseases (37 variants)
- GALM-related_disorder (8 variants)
- Galactosemia_4 (6 variants)
- not_specified (1 variants)
- Schizophrenia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GALM gene is commonly pathogenic or not. These statistics are base on transcript: NM_000138801.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 13 | 16 | ||||
missense | 52 | 57 | ||||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 5 | 1 | 53 | 16 | 4 |
Highest pathogenic variant AF is 0.000369863
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GALM | protein_coding | protein_coding | ENST00000272252 | 7 | 75328 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.88e-11 | 0.0581 | 125578 | 0 | 170 | 125748 | 0.000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.146 | 194 | 188 | 1.03 | 0.00000979 | 2201 |
Missense in Polyphen | 74 | 82.866 | 0.89301 | 947 | ||
Synonymous | -0.826 | 89 | 79.6 | 1.12 | 0.00000442 | 694 |
Loss of Function | 0.0512 | 16 | 16.2 | 0.986 | 7.73e-7 | 192 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000852 | 0.000852 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000924 | 0.000925 |
Finnish | 0.00286 | 0.00282 |
European (Non-Finnish) | 0.000535 | 0.000528 |
Middle Eastern | 0.000924 | 0.000925 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.000494 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Mutarotase converts alpha-aldose to the beta-anomer. It is active on D-glucose, L-arabinose, D-xylose, D-galactose, maltose and lactose (By similarity). {ECO:0000250, ECO:0000269|PubMed:12753898, ECO:0000269|PubMed:15026423}.;
- Pathway
- Glycolysis / Gluconeogenesis - Homo sapiens (human);Galactose metabolism - Homo sapiens (human);Glycolysis;Glycogenosis, Type VII. Tarui disease;Gluconeogenesis;Glycogenosis, Type IA. Von gierke disease;Glycogenosis, Type IC;Fanconi-bickel syndrome;Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease;Triosephosphate isomerase;Fructose-1,6-diphosphatase deficiency;Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1);Glycogenosis, Type IB;NOTCH-Ncore;D-galactose degradation V (Leloir pathway);trehalose degradation;sucrose degradation
(Consensus)
Recessive Scores
- pRec
- 0.189
Intolerance Scores
- loftool
- 0.826
- rvis_EVS
- -0.07
- rvis_percentile_EVS
- 48.54
Haploinsufficiency Scores
- pHI
- 0.147
- hipred
- N
- hipred_score
- 0.350
- ghis
- 0.429
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.976
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Galm
- Phenotype
Gene ontology
- Biological process
- glucose metabolic process;galactose metabolic process;galactose catabolic process via UDP-galactose
- Cellular component
- cytoplasm;extracellular exosome
- Molecular function
- aldose 1-epimerase activity;carbohydrate binding